Form 4 for HAE HAEMONETICS CORP
Accepted 2026-05-05 16:24:48 ET · period of report 2026-05-01 · accession 0000313143-26-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 16:24 | 2026-05-01 | HAE | DArecca James | EVP, CFO | F - Tax | $59.26 | -655 | 27.6K | -2% | -$38.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-01 | F | D | 655 | $59.26 | 27,637 | D | — | — | (F1) Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I. (F2) This number includes unvested RSUs previously reported. |